Cellspect
About:
Cellspect is a biotechnology business that creates biomarker-sensing technology for the transition from clinical to health tech markets.
Website: https://cellspect.com
Top Investors: Mitsubishi UFJ Capital, Mizuho Capital, Development Bank of Japan, Iwagin Jigyo Souzou Capital, Aflac Global Ventures
Description:
Cellspect is a development of clinical diagnostic methods by sensing disease markers.
Total Funding Amount:
3.53B JPY
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Morioka, Iwate, Japan
Founded Date:
2014-04-18
Contact Email:
info(AT)cellspect.com
Founders:
Number of Employees:
11-50
Last Funding Date:
2019-11-29
IPO Status:
Private
Industries:
© 2025 bioDAO.ai